These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 7516862)

  • 1. Parnaparin. A review of its pharmacology, and clinical application in the prevention and treatment of thromboembolic and other vascular disorders.
    Frampton JE; Faulds D
    Drugs; 1994 Apr; 47(4):652-76. PubMed ID: 7516862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the clinical use of the low-molecular-weight heparin, parnaparin.
    Camporese G; Bernardi E; Noventa F
    Vasc Health Risk Manag; 2009; 5():819-31. PubMed ID: 19851520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tinzaparin. A review of its pharmacology and clinical potential in the prevention and treatment of thromboembolic disorders.
    Friedel HA; Balfour JA
    Drugs; 1994 Oct; 48(4):638-60. PubMed ID: 7528134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enoxaparin. A reappraisal of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disease.
    Noble S; Peters DH; Goa KL
    Drugs; 1995 Mar; 49(3):388-410. PubMed ID: 7774513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nadroparin calcium. A review of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disorders.
    Barradell LB; Buckley MM
    Drugs; 1992 Nov; 44(5):858-88. PubMed ID: 1280570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enoxaparin. A review of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disorders.
    Buckley MM; Sorkin EM
    Drugs; 1992 Sep; 44(3):465-97. PubMed ID: 1382939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reviparin: a review of its efficacy in the prevention and treatment of venous thromboembolism.
    Wellington K; McClellan K; Jarvis B
    Drugs; 2001; 61(8):1185-209. PubMed ID: 11465877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarction.
    Wang XK; Zhang Y; Yang CM; Wang Y; Liu GY
    Clin Drug Investig; 2006; 26(6):341-9. PubMed ID: 17163268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures.
    Handoll HH; Farrar MJ; McBirnie J; Tytherleigh-Strong G; Awal KA; Milne AA; Gillespie WJ
    Cochrane Database Syst Rev; 2000; 2002(2):CD000305. PubMed ID: 10796339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical potential of low molecular weight heparins.
    Levine MN; Hirsh J
    Baillieres Clin Haematol; 1990 Jul; 3(3):545-54. PubMed ID: 2176904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parnaparin : a review of its use in the management of venous thromboembolism, chronic venous disease and other vascular disorders.
    McKeage K; Keating GM
    Drugs; 2008; 68(1):105-22. PubMed ID: 18081375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and safety of the low-molecular-weight heparin CY 216 in the prevention of fatal pulmonary embolism and thromboembolic death in general surgery. A multicentre, double-blind, randomized, controlled clinical trial versus placebo (STEP). STEP Study Group.
    Pezzuoli G; Neri Serneri GG; Settembrini PG; Coggi G; Olivari N; Negri G; Codemo R; Galli G; Roveri S
    Haemostasis; 1990; 20 Suppl 1():193-204. PubMed ID: 1964662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low molecular weight heparin (parnaparin) versus calcium heparin in the prevention of thromboembolic disease in general surgery].
    Gioè FP; Arcara M; Scaffidi Abbate F; Mercadante T
    Minerva Chir; 1994 Jun; 49(6):581-4. PubMed ID: 7970064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
    Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures.
    Handoll HH; Farrar MJ; McBirnie J; Tytherleigh-Strong G; Milne AA; Gillespie WJ
    Cochrane Database Syst Rev; 2002; (4):CD000305. PubMed ID: 12519540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
    Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
    Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use of parnaparin in major and minor orthopedic surgery: a review.
    Bugamelli S; Zangheri E; Montebugnoli M; Guerra L
    Vasc Health Risk Manag; 2008; 4(5):983-90. PubMed ID: 19183746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why low molecular weight heparin?
    Mammen EF
    Semin Thromb Hemost; 1990 Oct; 16 Suppl():1-4. PubMed ID: 1962897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of once daily parnaparin and unfractionated heparin in unstable angina pectoris: PRIME CARE study.
    PRIME CARE Study Investigators Group
    Indian Heart J; 2005; 57(6):648-54. PubMed ID: 16521631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.